Not Just a Flash in the Pan, Clinical Pearls for Hormone
Not Just a Flash in the Pan, Clinical Pearls for Hormone Therapy in the Treatment of Breast Cancer
ACPE UAN: 0179-9999-18-023-L01-P/T
ULM School of Pharmacy, Shreveport, LA
August 30, 2018
6:00 pm
TYPE OF ACTIVITY/WHO SHOULD ATTEND:
This knowledge-based activity is of importance to all pharmacists and pharmacy technicians.
LEARNING OBJECTIVES:
At the conclusion of this activity, pharmacists should be able to:
1. Explain the place in therapy of tamoxifen (TAM) and aromatase inhibitors (AIs) in the treatment of breast cancer.
2. Review the mechanisms of action of TAM and AIs.
3. Discuss common and severe adverse effects seen with these medications.
4. Describe supportive care options related to postmenopausal adverse events including hot flashes and vaginal dryness.
5. Describe supportive care options and screening recommendations related to non-postmenopausal adverse events.
• Tamoxifen: venous thromboembolism and endometrial cancer
• AIs: arthralgias and myalgias and osteoporosis
At the conclusion of this activity, Technicians should be able to:
1. Identify the indications for tamoxifen (TAM) and aromatase inhibitors (AIs).
2. Explain the mechanism of action of TAM and AIs.
3. Describe pertinent adverse events seen with these medications.
4. Discuss necessary supportive care to prevent and treat adverse effects of TAM and AIs.
FACULTY: Jill Comeau, PharmD, BCOP, Associate Professor of Clinical Sciences, ULM School of Pharmacy
CONTINUING EDUCATION CREDIT: 1.0 hours of continuing education credit can be earned through the participation in and successful completion of this activity.
ACCREDITATION:
To receive credit, registrants must attend the activity; complete a Continuing Education Credit Report, including the Activity Evaluation, onsite, and submit upon activity completion; and, pay all applicable LSHP fees.
*NABP e-Profile ID: IMPORTANT INFORMATION ON HOW TO RECEIVE CREDIT—PLEASE READ:
Your NABP e-Profile ID is required to receive credit for this CE activity.
LSHP will no longer be issuing paper statements of credit. In October 2012, LSHP began using “CPE Monitor,” which is a national, collaborative effort by ACPE and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists and pharmacy technicians to track their completed continuing pharmacy education (CPE) credits. All pharmacists and pharmacy technicians must obtain their NABP e-Profile ID by going to www.nabp.net. Your NABP e-Profile ID is required to receive credit for this activity. If you have not obtained your NABP e-Profile ID yet, then please do so prior to this activity as you will have to provide your ID on paperwork that you will turn in at the activity. After this CE activity, LSHP will send to NABP and ACPE the amount of credit you received (using your e-Profile ID). Once this information is received by NABP, pharmacists and pharmacy technicians will be able to log in to access information about their completed CPE.
FEES: There are no fees for attendance at the meeting for LSHP members. For non-LSHP members, there will be a $10 fee for continuing education credit.
RSVP: To Amanda Storer by e-mail at [email protected] or 225-202-2633
SPONSORED BY: This activity is sponsored by the North Louisiana Society of Health-System Pharmacists.
Online registration not available.